Catherine Arnaudeau-Bégard

Catherine Arnaudeau-Bégard

Head EMEA Medical & Business Integrity at UCB
 

En poste chez UCB

Précédents : UCB, GlaxoSmithKline Biologicals, CEA Saclay, CNRS, Stockholm University

 

Précédents : Stockholm University, Université Paris 7 Denis Diderot

 

    En résumé

    Dear Networker, Thank you for clicking on my Viadeo profile. A few words about me: I'm a postdoctoral geneticist, specialized in cancer genetics and gene therapy. After gaining extended academic research experience in Sweden and in France, I joined the French Atomic Energy Commission, a government-funded technological research organization focused on defense, energy, information and health technologies. I then moved to GSK Biologicals (now called GSK Vaccines) worldwide headquarters in Belgium, where I led scientific disclosure activities across a portfolio of viral vaccines. I joined UCB worldwide headquarters in 2009 as Global Lead Publication Planning & Strategy CNS where I've increasingly taken greater responsibility, initially within the public disclosure and transparency arenas, then further focusing on external funding, patient services and healthcare data intelligence strategies. After several years spent in corporate headquarters, I've decided to move to EMEA Operations for a new challenge closer to the real world. I'm currently Head of Medical and Business Integrity for Europe Middle-East and Africa at UCB. I'm passionate about innovative thinking, disruptive thinking and Connection of Things: life is a super network! I aim to contribute moving the society from sick care to health care. Enjoy the reading and don't hesitate to reach out. Kind regards, Catherine

Parcours

 

Head EMEA Medical & Business Integrity

Chez UCB

De septembre 2016 à aujourd'hui
EMEA Operations, Brussels, Belgium Head of Medical and Business Integrity for Europe Middle-East and Africa at UCB.
 

Senior Director - Head of Information Intelligence & Integrity

Chez UCB

De mai 2015 à août 2016
Corporate Headquarters, Brussels, Belgium
 

Director / Senior Director - Head of Medical Affairs Center of Expertise

Chez UCB

De juin 2013 à avril 2015
Corporate Headquarters, Brussels, Belgium Leading a multidisciplinary team of experts in the areas of Shared Learning, Medical & Scientific Exchange and Public Disclosure. Scope: global healthcare principles, external engagements, transparency, disclosure intelligence Director June 2013 to June ...
Lire la suite
 

Director - Global Head Scientific Public Disclosure

Chez UCB

De juin 2011 à mai 2013
Corporate Headquarters, Brussels, Belgium Scope: external engagements, transparency, disclosure intelligence * February 2012 - May 2013: Global Medical Affairs Heading Global Publications, Global Review Committees, Investigator Initiated Studies, Grants and Donations activities. * June 2011 - ...
Lire la suite
 

Associate Director - Global Head of Publications

Chez UCB

De janvier 2009 à mai 2011
Corporate Headquarters, Brussels, Belgium Heading Global Publications activities in Global Medical Affairs * January 2009 – September 2009 (9 months) Global Lead - Publication Planning & Strategy CNS
 

Gobal Lead Publications Manager

Chez GlaxoSmithKline Biologicals

De novembre 2005 à décembre 2008
Global Biologicals Headquarters, Rixensart, Belgium Global Clinical Research & Development * January 2008 – December 2008 (1 year): GLOBAL LEAD PUBLICATIONS MANAGER * August 2006 – January 2008 (1 year 5 months): GLOBAL PUBLICATIONS MANAGER * November 2005 – July 2006 (9 months): GLOBAL ...
Lire la suite
 

Senior Scientist - Project Leader

Chez CEA Saclay

De 2003 à 2005
The French Atomic Energy Commission is a government-funded technological research organization focused on defense, energy, information and health technologies. French Atomic Energy Commission, Saclay, France Laboratory of radiobiology and genome study "Individual radiosensitivity and genetic ...
Lire la suite
 

Postdoctoral Research Scientist

Chez CNRS

De 2000 à 2003
National Centre for Scientific Research, Villejuif, France Laboratory of genetic instability and cancer Postdoctorate - EMBO long term fellowship & IARC fellowship "“Genetic correction of DNA repair deficient / cancer prone xeroderma pigmentosum group C human keratinocytes”
 

Stockholm University, Stockholm

PhD , Toxicological Genetics

De 1997 à 2000
Stockholm University, Stockholm, Sweden Department of genetic and cellular toxicology Doctorate “Carcinogenesis, genetic recombination and repair mechanisms in mammalian cells” Arnaudeau C. (2000) Mitotic recombination in mammalian cells. ISBN 91-7265-135-0. PhD thesis.
 

Junior Research Scientist - PhD student

Chez Stockholm University

De 1997 à 2000
Stockholm University, Stockholm, Sweden Department of genetic and cellular toxicology Doctorate “Carcinogenesis, genetic recombination and repair mechanisms in mammalian cells”
 

Université Paris 7 Denis Diderot, Paris

Magistère, Magistère de Génétique

De 1995 à 1998
* Training course - ERASMUS Student Exchange Program (6 months): Department of genetic and cellular toxicology, Stockholm University. “Study of intragenic recombination mechanisms in mammalian cells" * Training course (10 weeks): Laboratory of pharmacogenetics and approaches to the treatment of ...
Lire la suite

Compétences

 
  • Cancérologie
  • Financement de projet
  • Génétique
  • Industrie pharmaceutique
  • Management
  • Recherche médicale clinique
  • Recherche scientifique
  • Vaccins

Langues parlées